Evidence map›Paper›PMID 30049843›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma.

Ching Ying Lin, Hyunwoo Kwon, Guillermo O Rangel Rivera, Xue Li, Dongjun Chung, Zihai Li

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ching Ying Lin *Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Hyunwoo Kwon *Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Guillermo O Rangel RiveraDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina.
Xue LiDepartment of Urology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts.
Dongjun ChungDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-8072-5671
Zihai LiDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina. zihai@musc.edu.
Medical University of South Carolina · USBoston Children's Hospital · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
Molecular chaperones and immune toleranceR01AI077283 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2009 to 2021
$3.7M
Statistical Models for Genetic Studies, Using Network and Integrative AnalysisR01GM122078 · NIGMS · OHIO STATE UNIVERSITY · PI CHUNG, DONGJUN · 2016 to 2020
$1.9M
Thrombocytes in Cancer ImmunityR01CA188419 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$1.9M
Integration of inflammation and cancer by molecular chaperoneR01CA213290 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2017 to 2021
$860k
Algorithms for Literature-Guided Multi-Platform Identification of Cancer SubtypesR21CA209848 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHUNG, DONGJUN, KELEMEN, LINDA E · 2016 to 2017
$358k
NCI NIH HHS P01 CA186866NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA188419NCI NIH HHS R01 CA213290NCI NIH HHS R21 CA209848NIAID NIH HHS R01 AI077283NIGMS NIH HHS R01 GM122078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorCarcinoma, Squamous CellCombined Modality TherapyFemaleFollow-Up StudiesHead and Neck NeoplasmsHumansInflammation MediatorsLymphocytesMaleMiddle AgedNeutrophilsPrognosisRetrospective StudiesSex FactorsSurvival RateBiomarkers, TumorInflammation Mediators

Identifiers

PMID30049843
PMCPMC6170665
OpenAlexW2884747769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.